{"target_audience": "b2b", "is_medical": true, "ai_generated_title": "Sobi Share Count Rises to 357.6 Million After Employee Stock Issue", "body_html": "<p><strong>Stockholm -- [CURRENT_DATE] --</strong> Swedish Orphan Biovitrum AB (Sobi) reported its total share and vote count at 357,636,514 as of September 30, 2026, following the issuance of 223,677 new class C shares.</p><h5>Sobi issues new shares to fund employee incentive program</h5><p>The increase stems from class C shares created to fulfil commitments under Sobi's All Employee Programme, a long-term incentive scheme for permanent staff. Under a conversion clause in the company's articles of association, the class C shares were converted into common shares, bringing the total share count to 357,636,514, all of which are common shares carrying an equal number of votes.</p><h5>Company holds nearly 9.7 million shares in treasury</h5><p>Sobi disclosed that it holds 9,631,955 common shares as of the same date, representing shares repurchased or retained by the company itself. The disclosure was made under obligations set by the Swedish Financial Instruments Trading Act and was submitted for publication at 08:00 CEST on September 30, 2026.</p><h5>Biopharma group employs roughly 2,000 across five regions</h5><p>Sobi, listed on Nasdaq Stockholm under the ticker SOBI, generated SEK 28 billion in revenue in 2025. The company employs approximately 2,000 staff across Europe, North America, the Middle East, Asia and Australia, focusing on rare disease therapies.</p>", "meta_description": "Sobi's total shares and votes reached 357,636,514 after issuing 223,677 class C shares under its employee incentive program, per a September 30, 2026 disclosure.", "seo_keywords": "Sobi, Swedish Orphan Biovitrum, share issuance, class C shares, Nasdaq Stockholm, employee incentive program, biopharma, rare disease", "companies": ["Swedish Orphan Biovitrum AB (Sobi)"], "industries": ["Biopharmaceuticals"], "markets_regions": ["Sweden", "Europe"], "news_type": ["regulatory_update", "financial_disclosure"], "themes": ["corporate_governance", "employee_compensation"], "products": [], "events": [], "cta_text": "Investors can review Sobi's regulatory filings and investor relations updates for further details on share structure changes.", "learn_more": "https://sobi.com", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}